ArticleFrontiers in psychology2019
Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life.
Article in Frontiers in psychology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Evaluating the long-term (Three Year) durability of brief interventions targeting risk factors for psychopathology.Journal of anxiety disorders · 2023Trial
- Metacognitive therapy versus cognitive-behavioral therapy in adults with generalized anxiety disorder: A 9-year follow-up study.Brain and behavior · 2021Trial
- Metacognitive therapy and work-focus for patients with depression, anxiety or comorbid depression and anxiety on sick leave: a single-centre, open-label randomised controlled trial.EClinicalMedicine · 2025Article
- Associations between employment status, type of occupation, and mental health problems in a treatment seeking sample.Frontiers in psychology · 2025Article
- Theory of Mind, Attachment and Metacognitive Functions in Depression.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2025Article
- Generic group metacognitive therapy for depression in specialized mental health care: an open trial with 6- and 12-month follow-ups.Frontiers in psychiatry · 2025Article
- Metacognitive Therapy for People Experiencing Persistent Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Preliminary Multiple Case-Series Study.Neurotrauma reports · 2024Article
- Metacognitive therapy for depression.Cogent mental health · 2024Article
- The psychometric properties of positive and negative beliefs about the rumination scale in Chinese undergraduates.BMC psychology · 2023Article
- Association of Depressive and Somatic Symptoms with Heart Rate Variability in Patients with Traumatic Brain Injury.Journal of clinical medicine · 2022Article
- Work after mental-health-related absence: a qualitative study of perceived change after a combination of metacognitive therapy and work-focused interventions.BMC public health · 2022Article
- Metacognitions and brooding predict depressive symptoms in a community adolescent sample.BMC psychiatry · 2022Article
- Relationships between depression, anxiety, type D personality, and worry and rumination in patients with coronary heart disease.Frontiers in psychology · 2022Article
- Article
- Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study.BMC psychiatry · 2020Article
- Temporal and Reciprocal Relations Between Worry and Rumination Among Subgroups of Metacognitive Beliefs.Frontiers in psychology · 2020Article
- The Function of Casual Sex Action and Inaction Regret: A Longitudinal Investigation.Evolutionary psychology : an international journal of evolutionary approaches to psychology and behaviorArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A major challenge in the treatment of depression has been high relapse rates following treatment. The current study reports results from a 3-year follow-up of patients treated with metacognitive therapy (MCT). Thirty-four of the 39 patients enrolled in the original study attended assessment (participation rate of 87%). There were large reductions in symptoms of depression, anxiety, interpersonal problems, and worry, as well as metacognitive beliefs. Three patients fulfilled diagnostic criteria for axis-I disorders: one with depression and two with generalized anxiety disorder. Sixty percent had not experienced any new depressive episodes in the 3-year follow-up period, and the static relapse rates were low (11-15%). Recovery rates ranged from 69 to 97% depending upon the four different criteria used. Nevertheless, 26% had sought out treatment for depression or other psychological difficulties. Most patients (70%) had experienced negative life events in the follow-up period, but these events did not influence current depression severity. Return to work outcomes were encouraging, as eight out of 13 patients that had been on benefits were no longer receiving benefits. Life satisfaction ratings showed mean scores around 70 (on a 0-100 scale) and showed a moderate to strong negative correlation with depression severity. In conclusion, MCT appears to be promising with respect to long-term effect. Randomized controlled trials should investigate if the long-term effect of MCT surpasses that of other evidence-based treatments for depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.